C4 Therapeutics Inc (NAS:CCCC) Stock News, Headlines & Updates
C4 Therapeutics Inc Stock News from GuruFocus
- 1
May 07, 2025
C4 Therapeutics (CCCC) Exceeds Revenue Expectations and Advances Key Drug Development | CCCC Stock News
GuruFocus News • 6:51am
C4 Therapeutics Inc (CCCC) Q1 2025 Earnings: EPS Loss of $0.37 Beats Estimate, Revenue Surges to $7.2 Million
GuruFocus News • 6:38am
C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights
Marketwired • 6:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news